|
|
d'Alessandri, S., Axilais, M. - C., Bernard, V., Dentan, A., Devaud, G., Dupertuis, V., et al. (1998). Points de vue sur les toxicodépendances des femmes en Suisse romande : enquête sur la demande et l'offre d'aide spécialement destinée aux femmes (Groupe de travail Femmes dépendances, Ed.). Lausanne: Groupe de travail Femmes dépendances.
|
|
|
|
Institut universitarie de médecine sociale et préventive. (2004). Thematisches Heft : Männer die Sex mit Männern haben (MSM) : Studienauszüge. Lausanne: Institut universitaire de médecine sociale et préventive.
Keywords: health promotion
|
|
|
|
Department of Health of England, Scottish Office Home and Health Department, & Welsh Office. (1991). Drug misuse and dependence : guidelines on clincal management : report of a medical working group. London: Her Majesty's Stationery Office (HMSO).
Keywords: health promotion; recommendations or guidelines; health care professionals; physician; social worker; pharmacist; AOD use, abuse, and dependence; AOD dependent; AOD user; risk assessment; AOD effects and AODR problems; AODR mortality; harm reduction; communicable disease; HIV infection; viral hepatitis; diagnosis; health; mental health; psychological development; hair analysis; urinalysis; hematologic test; treatment and maintenance; drug therapy; intravenous injection; opioids in any form; methadone maintenance; buprenorphine; codeine; naltrexone; clonidine; treatment goals; relapse prevention; international area; United Kingdom; drug substitution therapy
|
|
|
|
Federal Office of Public Health. (2002). Migration and Public Health : the Confederation's strategic orientation 2002-2006 : summarised version. Berne: Swiss Federal Offfice of Public Health (FOPH).
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2005). Annual report 2005 : selected issues. Selected issues. Luxembourg: Office for Official Publications of the European Communities.
Abstract: This Selected issue is not intended to present a systematic and exhaustive review either of all possible definitions of drug-related public nuisance or of all measures, provisions and policies aimed at reducing the problem in the European Union, nor does it aim to reflect precisely the situation regarding public nuisance in each of the countries concerned. Rather, it seeks to contribute to our understanding of the issues and problems related to a new – and somewhat still limited – area for intervention in Member States, candidate countries and Norway. This document aims to present the first EMCDDA qualitative insight into an emerging concern within drug policy debate, at both national and European levels. The alternatives to prison that may be offered to drug-using offenders cover a range of sanctions that may delay, avoid, replace or complement prison sentences for those drug users who have committed an offence normally sanctioned with imprisonment by national law. In this Selected issue, the focus is on those measures that have a drug-related treatment component. It will describe the political and legal background, the application and implementation, including common problems, and the effects of treatment as an alternative to imprisonment. Since the mid-1990s buprenorphine has increasingly become available in Europe as an alternative to methadone for the treatment of opiate dependence. In this Selected issue, the reasons why clinicians are attracted to this drug, as well as the costs and benefits of buprenorphine in comparison with other treatment options, are explored in detail, and, for the first time, the increasing popularity of buprenorphine for the treatment of opiate dependence in many European countries is documented.
Keywords: government and politics; international area; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2007). Cocaine and crack cocaine : a growing public health issue. Selected issues. Luxembourg: Office for Official Publications of the European Communities.
Abstract: In a Selected issue on ‘Cocaine and crack cocaine: a growing public health issue’ the EMCDDA shows that, in some European countries, there has been a marked increase in recent years in the use of cocaine, in treatment demands for cocaine problems and in seizures of the drug. The potential for cocaine use to have a major impact on public health is examined and special attention given to the health consequences of cocaine use, which are often not well recognised in existing reporting systems. Also examined are the challenges to providing effective treatment for cocaine and crack cocaine dependence.
Keywords: government and politics; international area; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2007). Drugs and driving (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: Since the late 1990s, much European and world research has addressed the issue of driving under the influence of psychoactive substances. This Selected issue on ‘Drugs and driving’ focuses on driving after taking cannabis and benzodiazepines. Country responses were analysed to determine the prevalence of these substances among drivers and studied in the context of policy and legislation, law enforcement and prevention.
Keywords: government and politics; international area; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2008). Drugs and vulnerable groups of young people (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: ‘With up to 2 million problem drug users in the EU, it’s high time to raise awareness of vulnerable groups, especially youth, on the risks of drug taking.’ European Commission Vice-President Jacques Barrot, September 2008. Social policy in Europe has long identified disadvantaged populations who manifest potential for social exclusion. These ‘vulnerable groups’ are specific groups among the wider population that may be more prone to a range of problems, from ill health, substance use and poor diet, to lower educational achievement. Groups of young people identified as vulnerable — examples include children in care institutions or homeless young people — might be prone to earlier, more frequent, or more problematic drug use. They might also experience faster progression to problem drug use.
Keywords: government and politics; prevention; AOD use, abuse, and dependence; target group; adolescent; international area; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2008). National drug-related research in Europe (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: Drug-related research is crucial to understanding Europe’s drug problems. Research enables Europe to learn lessons from the past, by identifying historical patterns of drug use, and studying the cycles and variations in the use of substances. Research sharpens Europe’s awareness and monitoring of the present. It provides surveys and data on the scope and scale of drug problems, and looks into emerging trends and new patterns in drug use. Research helps Europe to prepare for the future, by looking at practical issues such as resource allocation, best practices, the piloting of innovative approaches to managing problem drug use.
Keywords: government and politics; AOD use, abuse, and dependence; history; research; international area; Europe
|
|
|
|
Rocky Mountain Center for Health Education and Promotion. (2001). Harm reduction : a review of the literature. Lakewood: Rocky Mountain Center for Health Education and Promotion (RMCHEP).
Keywords: harm reduction; prevention; HIV infection; Aids; target group; history; addiction; United States; literature review
|
|
